Pamela Klein

Pamela M.
Klein is the founder of Pmk Bioresearch, serving as President since 2008.
Current jobs include Independent Non-Executive Director at argenx SE since 2016, Independent Director & Board of Directors at Ona Therapeutics SL, Independent Director; Board of Directors at Frontier Medicines Corp.
since 2023, Independent Director; Board of Directors at Sardona Therapeutics, Inc. since 2023, Venture Partner at Ysios Capital Partners SGEIC SA since 2020, and Advisor at Proxenia Venture Partners LLC.
Former jobs include Chairman at I-Mab in 2024, Non-Executive Director at Patrys Ltd. from 2019 to 2025, Research Director-NCI Navy Breast Center at National Cancer Institute from 1995 to 2001, Independent Director at F-Star Therapeutics, Inc. from 2019 to 2020, Director at F-Star Therapeutics, Inc., Board of Directors at F-Star Therapeutics, Inc. from 2019 to 2020, Independent Director at F-star Therapeutics, Inc. from 2020 to 2023, Independent Director at Jiya Acquisition Corp., Vice President-Development at Genentech, Inc. from 2001 to 2007, Chief Medical Officer at Syndax Pharmaceuticals, Inc., Chief Medical Officer at Intellikine LLC from 2008 to 2011, and Chief Medical Officer at Olema Pharmaceuticals, Inc. from 2018 to 2022.
Education includes a doctorate from Stritch School of Medicine conferred in 1992 and a doctorate from The California State University.